Pristimerin, a Triterpenoid, Inhibits Tumor Angiogenesis by Targeting VEGFR2 Activation

Molecules - Switzerland
doi 10.3390/molecules17066854
Full Text
Abstract

Available in full text

Date
Authors
Publisher

MDPI AG

Related search

A DNA Vaccine Targeting Angiomotin Inhibits Angiogenesis and Suppresses Tumor Growth

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2006English

Reactive Oxygen Species (ROS)-inducing Triterpenoid Inhibits Rhabdomyosarcoma Cell and Tumor Growth Through Targeting Sp Transcription Factors

Molecular Cancer Research
Cancer ResearchOncologyMolecular Biology
2019English

Nanotechnology-Mediated Targeting of Tumor Angiogenesis

Vascular Cell
Computer NetworksDevelopmental NeuroscienceNeurologyCell BiologyCommunications
2011English

Triggering Tumor Immunity Through Angiogenesis Targeting

Clinical Cancer Research
Cancer ResearchOncology
2007English

Targeting the Tumor Microenvironment: Focus on Angiogenesis

Journal of Oncology
Oncology
2012English

Knockdown of Long Non-Coding RNA XIST Increases Blood–tumor Barrier Permeability and Inhibits Glioma Angiogenesis by Targeting miR-137

Oncogenesis
Cancer ResearchMolecular Biology
2017English

miR‑337‑3p Inhibits Gastric Tumor Metastasis by Targeting ARHGAP10

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2019English

Inhibition of Tumor Endothelial ERK Activation, Angiogenesis, and Tumor Growth by Sorafenib (BAY43-9006)

American Journal of Pathology
Forensic MedicinePathology
2006English

MicroRNA-26b-5p Inhibits Mouse Liver Fibrogenesis and Angiogenesis by Targeting PDGF Receptor-Beta

Molecular Therapy - Nucleic Acids
Drug DiscoveryMolecular Medicine
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy